ClinicalTrials.gg
Active, not recruitingNCT07475221APPA e-DelphiUpdated Sep 25, 2026

Expert Validation of an Autonomous Personalized Physical Activity Algorithm

An observational study in Experts in Physical Activity Prescription and Risk Health Screening, sponsored by Polytechnic Institute of Porto. Active, not recruiting at 1 site in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by Polytechnic Institute of Porto · Observational

Updated Sep 25, 2026Now Active, not recruitingPrimary completion movedGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
9
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to validate a personalized physical activity algorithm for risk screening and individualized exercise prescription using a modified online Delphi process. International experts in physical activity and exercise will evaluate the algorithm's components over two rounds of questionnaires, with consensus defined as ≥70% agreement. If needed, a focus group will resolve any remaining disagreements. Validation of this algorithm may support safer, more effective autonomous exercise, promoting adherence, improved health outcomes, and population-level benefits.

Read the detailed description

Study Phases - eDelphi Validation of the APPA Algorithm

Phase 1 - Round 1 (Initial Online Questionnaire):

The first phase consists of an online survey in which international experts in physical activity and exercise will evaluate the components of the personalized physical activity algorithm for health risk screening and individualized exercise prescription. Experts will assess the relevance, clarity, and clinical appropriateness of each item. Feedback from this round will identify items requiring modification or clarification.

Phase 2 - Round 2 (Re-evaluation):

The second phase consists of a consecutive online survey round, in which experts will re-evaluate the revised algorithm components based on feedback from Round 1. Experts will have the opportunity to adjust their ratings. This phase aims to move items closer to consensus (≥70% agreement).

Phase 3 - Optional Focus Group (if needed):

If consensus is not reached on specific items after Round 2, an online focus group will be conducted to discuss and resolve remaining disagreements. This discussion will help refine the algorithm and ensure agreement on all components.

02

Conditions studied

  • Experts in Physical Activity Prescription and Risk Health Screening

Browse trials for

Keywords

  • eDelphi
  • physical activity
  • Modified Delphi
  • Digital Health
  • Expert Consensus
  • Exercise Prescription
  • screening
  • health risk stratification
03

In context

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

This study's planned enrollment of 9 is below the median of 98 across 1,235 observational studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Polytechnic Institute of Porto is the lead sponsor of 14 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of international experts in the field of Physical Activity and Exercise. Participants will be identified based on their recognized scientific or professional experience and possession of a relevant doctoral degree. Recruitment will be primarily via institutional email invitations, supplemented by personal contacts when needed. Eligible experts will voluntarily participate in two rounds of an online modified Delphi questionnaire and, if required, an online focus group to resolve any remaining disagreements. The targeted panel size is 9 - 18 experts to ensure representativeness and methodological robustness.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Experts in Physical Activity and Exercise with recognized scientific or professional experience and a relevant doctoral degree.
  • Availability to complete two rounds of the online modified Delphi questionnaire.
  • Willingness to participate in an online focus group if consensus is not reached.
  • Ability and willingness to provide .

Exclusion criteria

Exclusion Criteria

  • Individuals unable to provide .
  • Individuals without access to a computer, smartphone, tablet, or other internet-enabled device necessary to complete the online survey.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
9 participants (estimated)
Patient registry
No

Groups and cohorts

  • Expert Panel

    Cohort of experts in physical activity and exercise with recognized scientific or professional experience and a relevant doctoral degree. Experts will validate a digital algorithm for health risk screening and individualized physical activity prescription via a modified online Delphi process. Two rounds of anonymous questionnaires will assess the relevance, clarity, and clinical appropriateness of algorithm components. If consensus (≥70% agreement) is not reached, a follow-up online focus group will resolve disagreements. Recruitment will be through institutional emails and professional networks. Participation is voluntary, with informed consent obtained. Panel size: 9-18 experts, consistent with Delphi methodology to ensure representativeness and robustness.

06

What researchers measure

Primary outcomes

  1. Expert consensus on algorithm components

    Consensus defined as ≥70% agreement among experts using a 9-point Likert scale in a two-round modified Delphi process evaluating the relevance and clarity of algorithm items.

    Time frame: Up to 2 months

07

Study locations

1 site
  • School of Health - Polytechnic Institute of Porto
    Porto, 4200-072, Portugal
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2026 to primary completion in Jun 2026, 3 months.

Of 490 non-industry observational studies under Motor Activity, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 48. This study's 3 months is below that.

Counting every sponsor, half of 500 studies reached it within 22 months; a quarter within 8 and three quarters within 48.

Primary completion moved once since we started tracking on Sep 25, 2026: May 2026 → Jun 2026, on Sep 25, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 12, 2026
First posted
Mar 16, 2026
StartActual
Mar 10, 2026
Primary completionActual
Jun 30, 2026was May 2026
CompletionEst.
Dec 2026
Last update
Sep 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Sep 25, 2026
Primary completion
May 2026→Jun 30, 2026 (actual)
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    Recruiting→Active, not recruiting
    Primary completion May 2026→Jun 30, 2026 (now actual)
    + 2 other changes: contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07475221
Lead sponsor
Polytechnic Institute of Porto
Collaborators
Center for Rehabilitation Research - Polytechnic Institute of Porto (IPP)
Responsible party
Maria Pereira Gomes (Master's Student, Polytechnic Institute of Porto) — Principal investigator
First posted
Mar 16, 2026
Start date
Mar 10, 2026
Primary completion
Jun 30, 2026
Completion
Dec 2026 (estimated)
Last update
Sep 25, 2026

Study contacts

Andreia SP Sousa
study director · Center for Rehabilitation Research
António M Montes
study director · Center for Rehabilitation Research
Anabela C Martins
study director · H&TR-Health & Technology Research Center, Coimbra Health School, Polytechnic University of Coimbra

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion